Inici › Colitis ulcerosa › Washington › Tacoma
Assaigs clínics de Colitis ulcerosa a Tacoma, WA
15 estudis de Colitis ulcerosa busquen participants en centres de Tacoma i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
ReclutantFase 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ReclutantFase 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
ReclutantFase 2
- Site 019, Tacoma
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Site US-029, Tacoma
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- GI Alliance Tacoma, Tacoma
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
ReclutantFase 2/3
- MultiCare Health System, Tacoma
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
ReclutantFase 3
- Washington Gastroenterology - Tacoma, Tacoma
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
ReclutantFase 4
- Washington Gastroenterology- GIA, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- GI Alliance Tacoma, Tacoma
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
ReclutantFase 2
- Digestive Health Specialists, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
ReclutantFase 3
- MultiCare Institute for Research & Innovation, Tacoma
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
ReclutantEstudi observacional
- Washington Gastroenterology, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
ReclutantFase 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
ReclutantFase 2
- Mirador Therapeutics Selected Site, Tacoma
Assaigs de Colitis ulcerosa en altres ciutats
- New York City, NY23 estudis
- Orlando, FL22 estudis
- Miami, FL21 estudis
- Houston, TX17 estudis
- San Antonio, TX16 estudis
- Chicago, IL15 estudis
- San Diego, CA15 estudis
- Tyler, TX14 estudis
- Colorado Springs, CO14 estudis
- Los Angeles, CA13 estudis
- St. Louis, MO13 estudis
- Washington, DC12 estudis
Altres estudis a Tacoma
- Càncer de pulmó de cèl·lules no petites20 estudis
- Càncer de mama18 estudis
- Mieloma múltiple13 estudis
- Càncer de pròstata11 estudis
- Malaltia de Crohn11 estudis
- Càncer metastàtic9 estudis
- Càncer colorrectal9 estudis
- Melanoma7 estudis
- Càncer d'ovari7 estudis
- Càncer (tots els tipus)6 estudis
- Càncer de pàncrees6 estudis
- Obesitat6 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.